Agency Forms Undergoing Paperwork Reduction Act Review

[Federal Register Volume 64, Number 9 (Thursday, January 14, 1999)]
[Notices]
[Pages 2494-2495]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-822]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[30 DAY-06-99]


Agency Forms Undergoing Paperwork Reduction Act Review

    The Centers for Disease Control and Prevention (CDC) publishes a 
list of information collection requests under review by the Office of 
Management and Budget (OMB) in compliance with the Paperwork Reduction 
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call 
the CDC Reports Clearance Officer at (404) 639-7090. Send written 
comments to CDC, Desk Officer; Human Resources and Housing Branch, New 
Executive Office Building, Room 10235; Washington, DC 20503. Written 
comments should be received within 30 days of this notice.

Proposed Projects

    1. Multi-Center Cohort Study to Assess the Risk and Consequences of 
Hepatitis C Virus Transmission from Mother to Infant (0920-0344)--
Extension--The National Center for Infectious Diseases--The purpose of 
the study is to determine the incidence of vertical hepatitis C virus 
(HCV) transmission, to assess risk factors for vertical HCV 
transmission, to assess the clinical course of disease among infants 
with HCV infection, and to assess diagnostic methods for detecting HCV 
infection in infants. Respondents for the study will be anti-HCV 
positive mothers. We are requesting a extension to complete data 
collection for this study. The respondents will be remunerated for 
travel costs; provided well-child visits and free vaccinations for 
infants enrolled in the study; and, provided anti-HCV testing to all 
family members free of charge. The total annual burden hours are 53.

----------------------------------------------------------------------------------------------------------------
                                                                                     Number of     Avg. burden/
              Respondents                       Form name            Number of      responses/     response  (in
                                                                    respondents     respondent         hrs.)
----------------------------------------------------------------------------------------------------------------
Mothers...............................  Form G..................             300               8            0.10
----------------------------------------------------------------------------------------------------------------
Note: The annualized response burden is estimated to be 240 hours/4.5 years= 53 hours.

    2. Requirement for a Special Permit to Import Cynomolgus--African 
Green or Rhesus Monkeys--(0920-0263)--Extension--National Center for 
Infectious Disease (NCID) Division of Quarantine--A registered importer 
nonhuman primates must submit to the Director, CDC, a written plan 
which specifies the steps that will be taken to prevent exposure of 
persons and animals during the entire importation and quarantine 
process for the arriving nonhuman primates. Under the special permit 
arrangement, registered importers must submit a plan to CDC for the 
importation and quarantine if they wish to import the specific monkeys 
covered. The plan must address disease prevention procedures to be 
carried out in every step of the chain of custody of such monkeys, from 
embarkation in the country of origin to release from quarantine. 
Information such as species, origin and intended use for monkeys, 
transit information, isolation and quarantine procedures, and 
procedures for testing of quarantined animals is necessary for CDC to 
make public health decisions. This information enables CDC to evaluate 
compliance with the

[[Page 2495]]

standards and determine whether the measures being taken to prevent 
exposure of persons and animals during importation are adequate. Once 
CDC is assured, through the monitoring of shipments (normally no more 
than 2), that the provisions of a special permit plan are being 
followed by a new permit holder, and that the use of adequate disease 
control practices is being demonstrated, the special permit is extended 
to cover the receipt of additional shipments under the same plan for a 
period of 180 days, and may be renewed upon request. This eliminates 
the burden on importers to repeatedly report identical information, 
requiring only that specific shipment itineraries and information on 
changes to the plan which require approval be submitted.
    The respondents are commercial or not-for-profit importers of 
nonhuman primates. We are requesting clearance for 3 years. Total 
annual burden hours are 14.

----------------------------------------------------------------------------------------------------------------
                                                                                     Number of     Avg. burden/
                           Respondents                               Number of      responses/    responses  (in
                                                                    respondents     respondents        hrs.)
----------------------------------------------------------------------------------------------------------------
Businesses or organizations.....................................               2
                                                                               3
                                                                              15               5
                                                                                               5
                                                                                               5             0.5
                                                                                                             0.1
                                                                                                             0.1
----------------------------------------------------------------------------------------------------------------

Nancy Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 99-822 Filed 1-13-99; 8:45 am]
BILLING CODE 4163-18-P